Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Dec 31

PMID 34970555

Authors

Abdelkrim Hmadcha

Bernat Soria

Robert C Zhao

Tarik Smani

Israel Valverde

Affiliations

Soon will be listed here.

References

Townsend J, Hassler H, Wang Z, Miura S, Singh J, Kumar S . The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Lancet Microbe. 2021; 2(12):e666-e675. PMC: 8486316. DOI: 10.1016/S2666-5247(21)00219-6. View

Lanzoni G, Linetsky E, Correa D, Cayetano S, Alvarez R, Kouroupis D . Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med. 2021; 10(5):660-673. PMC: 8046040. DOI: 10.1002/sctm.20-0472. View

Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W . Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020; 38(1):10-18. DOI: 10.12932/AP-200220-0773. View

Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

Zhang H, Penninger J, Li Y, Zhong N, Slutsky A . Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46(4):586-590. PMC: 7079879. DOI: 10.1007/s00134-020-05985-9. View

Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q . Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020; 11(2):216-228. PMC: 7069465. DOI: 10.14336/AD.2020.0228. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Yang L, Han Y, Nilsson-Payant B, Gupta V, Wang P, Duan X . A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell. 2020; 27(1):125-136.e7. PMC: 7303620. DOI: 10.1016/j.stem.2020.06.015. View

Yan Y, Pang Y, Lyu Z, Wang R, Wu X, You C . The COVID-19 Vaccines: Recent Development, Challenges and Prospects. Vaccines (Basel). 2021; 9(4). PMC: 8067284. DOI: 10.3390/vaccines9040349. View

10.

Olliaro P, Torreele E, Vaillant M . COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021; 2(7):e279-e280. PMC: 8057721. DOI: 10.1016/S2666-5247(21)00069-0. View

11.

Tay M, Poh C, Renia L, Macary P, Ng L . The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20(6):363-374. PMC: 7187672. DOI: 10.1038/s41577-020-0311-8. View

12.

Lan L, Xu D, Ye G, Xia C, Wang S, Li Y . Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020; 323(15):1502-1503. PMC: 7047852. DOI: 10.1001/jama.2020.2783. View

13.

Hmadcha A, Abdelkrim H, Dominguez-Bendala J, Juan D, Wakeman J, Jane W . The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med. 2009; 13(8A):1464-75. PMC: 3828859. DOI: 10.1111/j.1582-4934.2009.00837.x. View

14.

Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y . Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020; 5(1):172. PMC: 7450163. DOI: 10.1038/s41392-020-00286-5. View

15.

Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J . Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020; 323(16):1582-1589. PMC: 7101507. DOI: 10.1001/jama.2020.4783. View

16.

Liang B, Chen J, Li T, Wu H, Yang W, Li Y . Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report. Medicine (Baltimore). 2020; 99(31):e21429. PMC: 7402800. DOI: 10.1097/MD.0000000000021429. View

17.

Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C . Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19. Front Med. 2020; 14(5):664-673. PMC: 7406954. DOI: 10.1007/s11684-020-0810-9. View

18.

Hui D, Zumla A . Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019; 33(4):869-889. PMC: 7127569. DOI: 10.1016/j.idc.2019.07.001. View

19.

Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y . Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif. 2020; 53(12):e12939. PMC: 7645923. DOI: 10.1111/cpr.12939. View

20.

Verma H, Farran B, Bhaskar L . Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antib Ther. 2021; 3(2):115-125. PMC: 7314270. DOI: 10.1093/abt/tbaa010. View